Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: Review of all reported cases and development of a clinical diagnostic paradigm-Reference-Cited by-同舟云学术

Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: Review of all reported cases and development of a clinical diagnostic paradigm

Published:2013-08 Issue:2 Volume:51 Page:71-75
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Jaffray Julie A.,Mitchell W. Beau,Gnanapragasam Merlin Nithya,Seshan Surya V.,Guo Xinhuo,Westhoff Connie M.,Bieker James J.,Manwani Deepa

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference19 articles.

1. Congenital dyserythropoietic anemias;Iolascon;Curr. Opin. Hematol.,2011

2. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II;Schwartz;Nat. Genet.,2009

3. Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25;Lind;Hum. Mol. Genet.,1995

4. A novel EKLF mutation in a patient with dyserythropoietic anemia: the first association of EKLF with disease in man;Singleton;ASH Abstracts,2009

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comment on: Congenital dyserythropoietic anemia type IV with KLF1 E325K mutation: A new case with dysmorphic male genitalia. Report of a second case;Pediatric Blood & Cancer;2024-08-27

2. Congenital dyserythropoietic anemia type IV with KLF1 E325K mutation: A new case with dysmorphic male genitalia;Pediatric Blood & Cancer;2024-03-24

3. Erythroid Krüppel-Like Factor (KLF1): A Surprisingly Versatile Regulator of Erythroid Differentiation;Advances in Experimental Medicine and Biology;2024

4. Novel human cellular model of CDA IV enables comprehensive analysis revealing molecular basis of disease phenotype;Blood Journal;2023-04-21

5. Modelling the erythroblastic island niche of dyserythropoietic anaemia type IV patients using induced pluripotent stem cells;Frontiers in Cell and Developmental Biology;2023-04-11